创新药板块盘初调整 奥赛康触及跌停

Group 1 - The innovative drug sector experienced an initial adjustment, with several companies, including Aosaikang, hitting the daily limit down [1] - Other companies such as Guangshengtang, Jimin Health, Huilong Pharmaceutical-W, Saili Medical, Rongchang Bio, and Wanbangde also saw declines [1]